Government has no plan to allow rapid kits: DGDA

Ershad Kamol | Published: 22:31, Apr 27,2020 | Updated: 00:13, Apr 28,2020


The government does not have any plan to allow rapid kits to test COVID-19 patients though 24 private companies applied for permission for the imported rapid kits, the directorate general of drug administration said on Monday.

Drug admin director general Mahbubur Rahman, in a press briefing at the health ministry, further pointed out that World Health Organisation also did not recommend using rapid kits for COVID-19 test arguing that such kits gave wrong results in over 60 per cent cases.

Mahbubur Rahman claimed that the DGDA had permitted Gonoshasthaya Kendra to proceed with its rapid kit development project for facilitating local invention for future use and extended its full support since the very first day when Gonoshasthaya Kendra approached with the proposal in March.

‘But, they are not following the procedures required for giving registration of a newly invented kit for its use. Rather, they tarnished the image of the agency and its officials,’ Mahbub claimed.

‘We will give registration of the kit if they can produce satisfactory validation and trial result after developing a protocol through a third-party contract research organization following the government rules,’ he said.

Mahbub claimed that the representatives of Gonoshasthaya Kendra on Sunday received work order for engaging a listed CRO — Eminence Clinical Research — for validation.

‘But few hours later they held a press conference accusing the drug administration of non-cooperation and intentionally creating hurdles for bribes,’ Mahbub said.

He also said that OMC Healthcare Pvt Ltd was developing RTPCR testing kits.

Gonoshasthaya Kendra founder Zafrullah Chowdhury, in response to the DGDA briefing, said on Sunday’s press conference that the directorate wanted to serve the business interest of some private companies other than that of the people.

‘We did not accept the concept of holding the validation test through a third party named Eminence Clinical Research that does not have a quality lab. Why can’t the government assign Bangabandhu Sheikh Mujib Medical University to test our invention in the public interest?’ Zafrullah asked.

‘They created the concept of engaging the third-party with the aim to make money and my position is against the evil system,’ he said.

Earlier on Saturday, the Gonoshasthaya unveiled its kits named Rapid Dot Blot but no government official was present at the ceremony, he said.

Want stories like this in your inbox?

Sign up to exclusive daily email